Spontaneous development of malignant phase hypertension in transgenic Ren-2 rats.

[1]  M. Picken,et al.  Continuous telemetric blood pressure monitoring and glomerular injury in the rat remnant kidney model. , 1993, The American journal of physiology.

[2]  D. Ganten,et al.  High blood pressure maintenance in transgenic mRen-2 vs. Lyon genetically hypertensive rats. , 1993, American Journal of Physiology.

[3]  D. Ganten,et al.  The role of the adrenal gland in hypertensive transgenic rat TGR(mREN2)27. , 1992, Endocrinology.

[4]  D. Ganten,et al.  Increased Vascular Angiotensin Formation in Female Rats Harboring the Mouse Ren‐2 Gene , 1992, Hypertension.

[5]  D. Ganten,et al.  Transgenic rats carrying the mouse renin gene--morphological characterization of a low-renin hypertension model. , 1992, Kidney international.

[6]  C. Edwards,et al.  Serotoninergic stimulation of aldosterone secretion in the rat in vivo: role of the renin-angiotensin system. , 1991, Journal of Endocrinology.

[7]  C. Grim,et al.  Prognosis and predisposing factors for essential malignant hypertension in predominantly black patients. , 1990, The American journal of cardiology.

[8]  D. Ganten,et al.  Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene , 1990, Nature.

[9]  M. Houston.  Pathophysiology, clinical aspects, and treatment of hypertensive crises. , 1989, Progress in cardiovascular diseases.

[10]  D. Webb,et al.  Measurement of plasma angiotensin II. , 1985, Clinical science.

[11]  T. Lohmeier,et al.  Malignant hypertensive crisis induced by chronic intrarenal norepinephrine infusion. , 1984, Hypertension.

[12]  B. Forsberg,et al.  Malignant hypertension and HLA antigens. , 2008, Tissue antigens.

[13]  J. Morton,et al.  The importance of the renin-angiotensin system in the development and maintenance of hypertension in the two-kidney one-clip hypertensive rat. , 1983, Clinical science.

[14]  J. Robertson,et al.  Malignant hypertension and oral contraceptives: four cases, with two due to the 30 ug oestrogen pill , 1982 .

[15]  P. Kincaid‐smith.  Renal pathology in hypertension and the effects of treatment. , 1982, British journal of clinical pharmacology.

[16]  J. Brown,et al.  Excess smoking in malignant-phase hypertension , 1979, British medical journal.

[17]  Sheehy Tw.  Letter: disseminated intravascular coagulation and severe falciparum malaria. , 1975 .

[18]  M. Tudor.  Letter: Treatment of spasticity. , 1974, Lancet.

[19]  F. Byrom.  The nature of malignancy in hypertensive disease. Evidence from the retina of the rat. , 1963, Lancet.

[20]  P. Kincaid‐smith,et al.  The clinical course and pathology of hypertension with papilloedema (malignant hypertension). , 1958, The Quarterly journal of medicine.

[21]  Clifford Wilson,et al.  RENAL CHANGES IN MALIGNANT HYPERTENSION , 1939 .

[22]  Clifford Wilson,et al.  RENAL CHANGES IN MALIGNANT HYPERTENSION: EXPERIMENTAL EVIDENCE , 1939 .